JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koster, A.
Right arrow Articles by Lincoff, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koster, A.
Right arrow Articles by Lincoff, M. A.
Related Collections
Right arrow Cardiovascular
Right arrow Blood
Right arrow Pharmacology

Anesth Analg 2006;103:540-544
© 2006 International Anesthesia Research Society
doi: 10.1213/01.ane.0000226098.95698.0f


CARDIOVASCULAR ANESTHESIA

Bivalirudin Provides Rapid, Effective, and Reliable Anticoagulation During Off-Pump Coronary Revascularization: Results of the "EVOLUTION OFF" Trial

Andreas Koster, MD*, Bruce Spiess, MD{ddagger}, Michael Jurmann, MD{dagger}, Cornelius M. Dyke, MD, Nicholas G. Smedira, MD§, Sol Aronson, MD#, and Michael A. Lincoff, MD||

From the Departments of *Anesthesia and {dagger}Cardiothoracic and Vascular Surgery, Deutsches Herzzentrum, Berlin, Germany; {ddagger}Department of Cardiothoracic Anesthesia, Virginia Commonwealth University, Richmond; Departments of §Cardiothoracic Surgery and ||Cardiovascular Medicine, The Cleveland Clinic Foundation, Ohio; ¶Gaston Memorial Hospital, Gastonia; and #Department of Anesthesiology, Duke University, Durham, North Carolina.

Address correspondence and reprint requests to Andreas Koster, MD, Deutsches Herzzentrum Berlin, Augustenburger Platz 1, D-13353 Berlin, Germany. Address e-mail to koster{at}dhzb.de.

In the EVOLUTION OFF trial, we evaluated the safety and efficacy of bivalirudin during off-pump coronary artery bypass grafting as compared with heparin-protamine. In this subanalysis of EVOLUTION OFF data of bivalirudin-treated patients, we assessed the pharmacokinetics (PK) and effectiveness of bivalirudin anticoagulation to achieve target activated clotting time (ACT)+ values. Data from 101 patients were assessed. A bolus of 0.75 mg/kg of bivalirudin was followed by a continuous infusion of 1.75 mg · kg–1 · h–1 during the grafting procedure. An ACT+ value of >300 s was the target. In four patients, PK data for bivalirudin were obtained. Only in exceptional cases were repeat fractional boluses or an increase of the infusion rate required. Assessment of the PK data showed a mean concentration of bivalirudin after the initial bolus of 11.0 ± 0.53 µg/mL and a mean concentration during infusion of 11.2 ± 2.32 µg/mL. Pearson’s correlation between bivalirudin concentrations and ACT+ values was 0.92. Bivalirudin PK data consistently exceeded concentrations of 6.5 µg/mL, which have been evaluated as effective during percutaneous coronary intervention. The correlation between bivalirudin levels and ACT+ values was good, and the target ACT+ values were almost always achieved. These results suggest that bivalirudin, given according to the current protocol, provides reliable and effective anticoagulation during off-pump coronary artery bypass graft surgery.




This article has been cited by other articles:


Home page
ChestHome page
T. E. Warkentin, A. Greinacher, A. Koster, and A. M. Lincoff
Treatment and Prevention of Heparin-Induced Thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Chest, June 1, 2008; 133(6_suppl): 340S - 380S.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
R. C. Becker
Emerging constructs to maintain safety among patients with acute coronary syndromes requiring surgical coronary revascularization
Eur. Heart J. Suppl., May 1, 2008; 10(suppl_D): D12 - D22.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
A. F. Merry
Focus on Thrombin: Alternative Anticoagulants
Seminars in Cardiothoracic and Vascular Anesthesia, December 1, 2007; 11(4): 256 - 260.
[Abstract] [PDF]




Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2006 by the International Anesthesia Research Society.